ICD triggers the release of damage-associated molecule patterns (DAMPs) from tumor cells, such as calreticulin (CRT), adenosine triphosphate (ATP), and high mobility group protein 1 (HMGB1), facilitating the recruitment and activation of tumor-specific CTLs. This evidence concerns the gene HMGB1 and neoplasm.